PetMed Express Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
PetMed Express wird ein jährliches Gewinn- und Umsatzwachstum von 103.7% bzw. 0.07% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 103.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 5.4% betragen.
Wichtige Informationen
103.7%
Wachstumsrate der Gewinne
103.72%
EPS-Wachstumsrate
| Specialty Retail Gewinnwachstum | 9.8% |
| Wachstumsrate der Einnahmen | 0.07% |
| Zukünftige Eigenkapitalrendite | 5.43% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 29 Apr 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
There's been a notable change in appetite for PetMed Express, Inc. ( NASDAQ:PETS ) shares in the week since its...PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates
PetMed Express, Inc. ( NASDAQ:PETS ) last week reported its latest annual results, which makes it a good time for...Recent updates
PETS: Rural King Partnership Will Shape Future Margins And Earnings Multiple
Analysts have trimmed their price target on PetMed Express to reflect a fair value update from $3.00 to $2.15 as they incorporate more moderate expectations for revenue contraction, profit margins, and a higher future P/E multiple into their models. What's in the News PetMed Express announced a partnership with Rural King to launch a new pet pharmacy offering across Rural King retail stores and digital platforms, expanding access to prescription medications, preventatives and pet health products for Rural King customers (Key Developments).Getting In Cheap On PetMed Express, Inc. (NASDAQ:PETS) Is Unlikely
It's not a stretch to say that PetMed Express, Inc.'s ( NASDAQ:PETS ) price-to-sales (or "P/S") ratio of 0.3x right now...Some Confidence Is Lacking In PetMed Express, Inc. (NASDAQ:PETS) As Shares Slide 26%
To the annoyance of some shareholders, PetMed Express, Inc. ( NASDAQ:PETS ) shares are down a considerable 26% in the...
Cost Cuts And Digital Upgrades Will Strain Future Margins
Optimism regarding savings from PetCareRx integration could jeopardize future profitability if anticipated savings do not materialize.PetMed Express: Dip Or Rip, A Buy After Earnings
Summary PetMed Express stock could surge or sink after this week's quarterly earnings release, but don't read too much into this near-term event. A disappointing earnings release won't necessarily shatter the bull case, and could, in fact, push this stock back down to "back up the truck" price levels. Conversely, even if PETS rallies on strong results, this may not capture all of the potential long-term upside. Even if it takes time to take shape, improvements in PetMed's operating performance could ultimately send the stock back to prices north of $15 per share. Read the full article on Seeking AlphaWe Think PetMed Express (NASDAQ:PETS) Can Easily Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Some PetMed Express, Inc. (NASDAQ:PETS) Shareholders Look For Exit As Shares Take 28% Pounding
PetMed Express, Inc. ( NASDAQ:PETS ) shares have retraced a considerable 28% in the last month, reversing a fair amount...PetMed Express: Why (And Why Not) The Rebound Could Continue
Summary PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turnaround continues. PetMed's management team is implementing a strategy change, not just cost-cutting measures, to continue improving the company's fiscal performance. Although many risks and uncertainties remain, given the outsized impact further improvements could have on the PETS stock price, at the very least add it to your watchlist. Read the full article on Seeking AlphaOptimistic Investors Push PetMed Express, Inc. (NASDAQ:PETS) Shares Up 28% But Growth Is Lacking
PetMed Express, Inc. ( NASDAQ:PETS ) shares have had a really impressive month, gaining 28% after a shaky period...PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
There's been a notable change in appetite for PetMed Express, Inc. ( NASDAQ:PETS ) shares in the week since its...PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates
PetMed Express, Inc. ( NASDAQ:PETS ) last week reported its latest annual results, which makes it a good time for...PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price
Key Insights Using the Dividend Discount Model, PetMed Express fair value estimate is US$7.95 Current share price of...A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)
Key Insights PetMed Express' estimated fair value is US$11.85 based on 2 Stage Free Cash Flow to Equity Current share...PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30
The board of PetMed Express, Inc. ( NASDAQ:PETS ) has announced that it will pay a dividend of $0.30 per share on the...The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
PetMed Express, Inc. ( NASDAQ:PETS ) will pay a dividend of $0.30 on the 27th of February. This makes the dividend...Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 3/31/2028 | 184 | 2 | N/A | N/A | 1 |
| 3/31/2027 | 180 | 1 | N/A | N/A | 1 |
| 3/31/2026 | 178 | -57 | N/A | N/A | 1 |
| 12/31/2025 | 187 | -65 | -23 | -17 | N/A |
| 9/30/2025 | 198 | -55 | -16 | -9 | N/A |
| 6/30/2025 | 212 | -44 | -5 | 1 | N/A |
| 3/31/2025 | 227 | -6 | 0 | 5 | N/A |
| 12/31/2024 | 236 | 0 | 1 | 5 | N/A |
| 9/30/2024 | 249 | -1 | -1 | 3 | N/A |
| 6/30/2024 | 262 | -3 | -9 | -5 | N/A |
| 3/31/2024 | 274 | -7 | 0 | 4 | N/A |
| 12/31/2023 | 277 | -3 | 2 | 7 | N/A |
| 9/30/2023 | 270 | -1 | 17 | 22 | N/A |
| 6/30/2023 | 265 | 1 | 17 | 22 | N/A |
| 3/31/2023 | 248 | 5 | 23 | 28 | N/A |
| 12/31/2022 | 259 | 9 | 23 | 27 | N/A |
| 9/30/2022 | 261 | 13 | 19 | 23 | N/A |
| 6/30/2022 | 263 | 17 | 23 | 25 | N/A |
| 3/31/2022 | 272 | 19 | 17 | 18 | N/A |
| 12/31/2021 | 279 | 22 | 26 | 28 | N/A |
| 9/30/2021 | 284 | 25 | 24 | 26 | N/A |
| 6/30/2021 | 292 | 27 | 48 | 51 | N/A |
| 3/31/2021 | 304 | 24 | 38 | 40 | N/A |
| 12/31/2020 | 312 | 31 | 37 | 39 | N/A |
| 9/30/2020 | 306 | 30 | 34 | 37 | N/A |
| 6/30/2020 | 300 | 28 | 25 | 28 | N/A |
| 3/31/2020 | 284 | 26 | 37 | 39 | N/A |
| 12/31/2019 | 274 | 25 | 33 | 35 | N/A |
| 9/30/2019 | 275 | 26 | N/A | 42 | N/A |
| 6/30/2019 | 276 | 31 | N/A | 23 | N/A |
| 3/31/2019 | 283 | 38 | N/A | 45 | N/A |
| 12/31/2018 | 286 | 41 | N/A | 34 | N/A |
| 9/30/2018 | 286 | 43 | N/A | 39 | N/A |
| 6/30/2018 | 282 | 41 | N/A | 46 | N/A |
| 3/31/2018 | 274 | 37 | N/A | 37 | N/A |
| 12/31/2017 | 270 | 35 | N/A | 51 | N/A |
| 9/30/2017 | 262 | 30 | N/A | 38 | N/A |
| 6/30/2017 | 256 | 27 | N/A | 48 | N/A |
| 3/31/2017 | 249 | 24 | N/A | 47 | N/A |
| 12/31/2016 | 242 | 22 | N/A | 30 | N/A |
| 9/30/2016 | 240 | 22 | N/A | 35 | N/A |
| 6/30/2016 | 236 | 21 | N/A | 23 | N/A |
| 3/31/2016 | 235 | 21 | N/A | 21 | N/A |
| 12/31/2015 | 229 | 20 | N/A | 25 | N/A |
| 9/30/2015 | 228 | 20 | N/A | 22 | N/A |
| 6/30/2015 | 228 | 18 | N/A | 29 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: PETS wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (3.5%).
Ertrag vs. Markt: PETS wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: PETS wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: PETSDie Einnahmen des Unternehmens (0.07% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.5% pro Jahr).
Hohe Wachstumseinnahmen: PETSDie Einnahmen des Unternehmens (0.07% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: PETSDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (5.4%).
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/07 23:05 |
| Aktienkurs zum Tagesende | 2026/05/07 00:00 |
| Gewinne | 2025/12/31 |
| Jährliche Einnahmen | 2025/03/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
PetMed Express, Inc. wird von 15 Analysten beobachtet. 1 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Erin Wilson Wright | BofA Global Research |
| Kristine Koerber | Citizens JMP Securities, LLC |
| David Westenberg | CL King & Associates, Inc. |